Department of Medicine, Karolinska Institute, Sweden.
Diab Vasc Dis Res. 2012 Jul;9(3):170-6. doi: 10.1177/1479164112451581.
People with disturbed glucose metabolism are at an increased risk for cardiovascular disease. This risk starts before diabetes, according to present definitions, is established. Early detection of impaired glucose tolerance and target-driven multifactorial management incorporating all risk factors in a broad sense may effectively improve the prognosis for these persons. Management includes early detection of glucose perturbations and preventing or delaying future diabetes among people with impaired glucose tolerance. In people with established diabetes, hypertension, hyperlipidaemia and hyperglycaemia are all important factors to monitor and, if these are above the recommended levels, to treat, first hand with lifestyle-oriented recommendations, although usually supported by pharmacological interventions. Since impaired glucose tolerance and type 2 diabetes mellitus are rapidly increasing in the population, glucose perturbations as the cause of cardiovascular disease manifestations will become more common. Development of macrovascular complications substantially impacts care costs, and proper management of these individuals will therefore not only decrease personal suffering but also clearly impact health care expenditures.
糖代谢紊乱人群患心血管疾病的风险增加。根据目前的定义,这种风险早在糖尿病确诊之前就已经存在。早期发现糖耐量受损,并进行目标导向的多因素管理,广义上涵盖所有危险因素,可能会有效改善这些人群的预后。管理包括早期发现血糖紊乱,并预防或延迟糖耐量受损人群的未来糖尿病发生。对于已确诊糖尿病的患者,高血压、高血脂和高血糖都是需要监测的重要因素,如果这些指标高于推荐水平,则首先通过生活方式建议进行治疗,尽管通常还需要药物干预支持。由于糖耐量受损和 2 型糖尿病在人群中的发病率迅速增加,作为心血管疾病表现的原因的血糖紊乱将变得更为常见。大血管并发症的发展极大地影响了医疗费用,因此,对这些患者的适当管理不仅会减轻个人痛苦,还会明显影响医疗保健支出。